Current Research Partners
Stanford University/Veterans Affairs Palo Alto Health Care
System (VAPAHCS)
Anne L. Friedlander, PhD., Director of the Major Project on Mobility within the Stanford Center on Longevity and Director of the Exercise Physiology Lab in the Clinical Studies Unit at the VAPAHCS.
http://longevity.stanford.edu/mobility/scl_affiliate_research/pods#2
TempusClinic-Los Gatos California
Mike Nichols, MD
http://www.tempusclinic.com
Athercare Fitness and Rehabilitation-Castro Valley, California
Don Chu, PhD
http://www.athercare.com
Human Performance Specialists-Tempe, Arizona
Thomas Incledon, PhD(c), RD, LD, LN, RPT, NSCA-CPT, CSCS
http://www.thomasincledon.com
Scottsdale Cardiovascular Research and Heart Failure Institute-Scottsdale, Arizona
Krishnaswami Vijayaraghavan, MD, MS, FACC, FACP
http://www.scresearch.org
Current Research Programs
Metabolic Syndrome
A recent occurrence has provided early evidence to support the initiation of research for another therapeutic application of the cyclic variations in altitude conditioning process. To discuss this confidentially, contact Allen Ruszkowkski at 951-699-2086.
Previous Research Programs
University of Hawaii
Researchers at the University of Hawaii have collected first-in-man scientific data on Cyclic Variations in Altitude Conditioning™ (CVAC™). The abstract was published, and presented at the 2006 American College of Sports Medicine annual meeting. Currently, the data acquired remains confidential in anticipation of publication, but the data can be shared contingent upon execution of an appropriate agreement of non-disclosure.
Please contact Allen Ruszkowski at 951-699-2086 or Lawrence Burgess, MD 808-692-1091 or click here to contact us by email.
The Effect of a Cyclic Variable Altitude Conditioning Program on
Arterial Oxygen Saturation Acclimation
Abstract:
Acclimation to altitude using a portable hypobaric chamber at sea
level may decrease the incidence of acute altitude sickness and improve
physical and mental performance when traveling from sea level to
altitude. PURPOSE: This study examined the effect of a cyclic variable
altitude conditioning program involving intermittent hypoxic exposure
at sea level, using a portable hypobaric chamber, on arterial oxygen
saturation (SaO2) at the following altitudes: 2740, 3660, 4570, 5490,
and 6,400 M. METHODS: Eight aerobically trained subjects completed
a hypoxic training protocol that progressively exposed them to higher
altitudes. Subjects acclimated for one hour per day, five days per
week, for seven weeks. The highest altitude was 3200 M in the first
week, 4420 M in the third week and progressed to 6860 M for the final
three weeks of exposure. The SaO2 values were determined using a
pulse oximeter equipped with an ear sensor prior to beginning the
conditioning program (week 1) and after week 3, prior to week 4 and
after week 7 of conditioning. RESULTS: Mean ± STD SaO2 values
prior to conditioning were 98 ± 0 % at sea level. The following
table presents the lowest SaO2 values recorded prior to and after
conditioning at five altitudes.
SaO2 at various altitudes
Week
|
2740 M> |
3360 M> |
4570 M |
2740 M |
4570 M |
1 |
90.4 ± 3.8 % |
86.0 ± 4.1 % |
80.9 ± 4.9 % |
88.3 ± 4.6 % |
78.9 ± 6.2 % |
3 |
94.3 ± 1.4 % |
90.3 ± 2.1 % |
86.0 ± 3.2 % |
93.1 ± 3.1 % |
86.1 ± 3.5 % |
| Week |
4570 M> |
5490 M> |
6400 M |
4570 M |
6400 M |
4 |
87.8 ± 2.6 % |
82.1 ± 3.7 % |
73.9 ± 4.0 % |
84.3 ± 5.6 % |
72.0 ± 6.0 % |
7 |
89.5 ± 2.3 % |
85.1 ± 4.1 % |
79.4 ± 5.6 % |
87.5 ± 5.2 % |
79.4 ± 5.3 % |
An ANOVA for repeated measures revealed significant differences between
SaO2 values between weeks 1 and 3, and weeks 4 and 7 (p<0.05).
CONCLUSION: It was concluded that cyclic variable altitude conditioning
resulted in an acclimation response such that arterial SaO2 was significantly
increased at altitude.
Authors:
Ronald K. Hetzler, FACSM, Ryan W. Sargent, Iris F. Kimura, Lawrence
Burgess, Michelle LaBotz, Andrew Nichols, FACSM, Kenneth Nakasone.
University of Hawaii, Honolulu, HI.
View
original abstract
Stanford University/Veterans Affairs Palo Alto Health Care
System (VAPAHCS)
An initial research study investigating the clinical applications of the CVAC process was completed in January 2007.
Principal investigator: Anne L. Friedlander, Ph.D., Associate Director for Education and Evaluation at VAPAHCS’s Geriatric Research Education and Clinical Center, and a consulting professor for the program in Human Biology at Stanford University.
This initial study tested the efficacy of the CVAC process on exercise performance. Moreover, it tested if CVAC could increase sea-level and altitude exercise performance with significantly less exposure time than traditional intermittent hypoxic exposure (IHE) techniques. As a result of the pilot data; a larger, more extensive study was initiated in 2Q07.
Download
related news release
|